Skip to main content

Table 5 Blood hematology values

From: Effects of oral adenosine-5′-triphosphate supplementation on athletic performance, skeletal muscle hypertrophy and recovery in resistance-trained men

 

Placebo

ATP

 

Before*

SEM

After

SEM

% Change

Before

SEM

After

SEM

% Change

p Value

WBC, x109/l

5.93

0.38

5.98

0.34

0.8

6.08

0.24

6.07

0.22

−0.1

0.67

RBC, x1012/l

5.16

0.10

5.19

0.09

0.7

5.13

0.04

5.07

0.05

−1.1

0.30

Hemoglobin, g/l

156

2.8

155

2.4

−1.0

157

2.2

156

2.0

−0.8

0.97

Hematocrit, l/l

0.46

0.01

0.46

0.01

0.0

0.47

0.01

0.46

0.01

−1.8

0.54

MCV, μm3

89.7

0.8

89.3

1.0

−0.5

90.6

0.8

89.7

0.8

−1.0

0.94

MCH, pg/cell

30.5

0.40

30.2

0.33

−1.1

30.4

0.32

30.5

0.44

0.3

0.42

MCHC, g/l

339

3.1

336

2.5

−0.9

334

3.9

340

4.4

2.1

0.16

RDW,%

13.4

0.1

13.4

0.1

0.0

13.1

0.1

13.2

0.1

0.8

0.62

Platelets, x109/l

247

9.0

236

9.1

−4.2

248

9.5

217

5.1

−12.5

0.64

Neutrophils,%

46.5

3.1

47.4

2.5

1.9

47.6

3.0

47.8

2.0

0.5

0.80

Lymphocytes,%

39.6

3.2

38.4

2.6

−3.0

39.0

2.8

38.8

1.7

−0.6

0.74

Monocytes,%

10.3

0.6

9.4

0.7

−8.7

9.3

0.5

9.6

0.6

3.0

0.57

Eosinophils,%

3.6

0.5

3.6

0.5

0.0

3.4

0.4

3.4

0.4

0.0

0.98

Basophils,%

0.6

0.2

0.7

0.2

16.7

0.4

0.2

0.4

0.2

−0.3

0.83

Neutrophils, x109/l

3.2

0.6

3.3

0.5

2.5

3.0

0.3

2.9

0.2

−2.3

0.27

Lymphocytes, x109/l

2.4

0.2

2.5

0.3

4.1

2.4

0.2

2.4

0.1

2.9

0.99

Monocytes, x109/l

0.67

0.08

0.62

0.08

−7.5

0.82

0.20

0.61

0.05

−25.6

0.62

Eosinophils, x109/l

0.21

0.02

0.21

0.02

0.0

0.21

0.03

0.22

0.03

4.4

0.32

Basophils, x109/l

0.02

0.01

0.01

0.01

−50.0

0.00

0.00

0.00

0.00

0.0

0.41

  1. *Values Before and After 12 weeks of either placebo or ATP (400 mg/d) administration.
  2. Standard error of the mean.
  3. P value for Trt*time effect, the model included data from weeks 4 and 8 (not shown).